Youre Expecting Results Too Quickly Many patients hope to lose a significant amount of weight within the first week or two
4 Other than being on GLP-1s, higher risk patients include: those in the dose-escalation phase and those with upper GI symptoms (eg, nausea, vomiting, dyspepsia, abdominal distension, and abdominal discomfort/pain). 4 And obviously, other high-risk group includes patients with comorbidities associated with delayed gastric emptying (eg, poorly controlled diabetes, Parkinsons disease, bowel dysmotility) as well as those on other drugs that slow gastric emptying (eg, opioids, tricyclic antidepressants, marijuana, alcohol)
These arent just weight loss drugstheyre metabolic modulators that can help reset insulin sensitivity, reduce visceral fat, and break through the metabolic resistance that perimenopause creates
GHS-R1a The ghrelin receptor - a cell-signal receiver - at which Ipamorelin acts